PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1808083
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1808083
The global flexible endoscopes market is projected to reach USD 3.07 billion by 2030, growing from USD 2.38 billion in 2025, at a CAGR of 5.1% during the forecast period.
Scope of the Report | |
---|---|
Years Considered for the Study | 2024-2030 |
Base Year | 2024 |
Forecast Period | 2025-2030 |
Units Considered | Value (USD billion) |
Segments | Type, Application, End User, and Region |
Regions covered | Asia Pacific, North America, Europe, Latin America, Middle East & Africa, and GCC Countries |
The growth of the flexible endoscopes market is driven by the rising demand for endoscopic procedures to diagnose and manage target conditions, such as colorectal cancer and inflammatory bowel diseases, and the need for early, minimally invasive interventions. Additionally, growing awareness regarding preventive healthcare is boosting procedural volumes.
Opportunities for players in the market emerge from the rising adoption of single-use flexible endoscopes, which address infection control concerns, and the rapidly expanding healthcare infrastructure in emerging economies. These areas offer untapped potential to market players due to increasing investments, better access to healthcare, and evolving patient care standards.
The colonoscopes segment accounted for the second-largest share of the flexible endoscopes market in 2024.
By type, the flexible endoscopes market is segmented into upper gastrointestinal endoscopes, colonoscopes, broncoscopes, sigmoidoscopes, laryngoscopes, pharyngoscopes, duodenoscopes, nasopharyngoscopes, rhinoscopes, and other types. Among these, the colonoscopes segment accounted for the second-largest market share in 2024, owing to the rising global incidence of colorectal cancer and increased awareness around early screening and diagnosis. Colonoscopies are critical in detecting precancerous polyps, ulcers, inflamed tissues, and other abnormalities within the colon and rectum, which makes them a preferred diagnostic tool among physicians. According to the CDC, approximately 142 million colonoscopies are performed annually in the US, highlighting their widespread adoption. Furthermore, in 2023, the American Cancer Society reported over 153,000 new colorectal cancer cases and 52,550 related deaths, as well as a concerning rise of this disease in younger populations. These alarming statistics have led to expanded screening guidelines and increased procedural volumes. The ability of colonoscopes to obtain tissue samples and provide real-time visual assessment enhances diagnostic precision, further supporting their demand. Ongoing technological advancements in high-definition imaging and patient comfort, along with strong support from healthcare providers and governments, further drive growth in this segment.
The bronchoscopy segment accounted for the second-largest share of the flexible endoscopes market in 2024.
By application, the flexible endoscopes market has been divided into gastrointestinal endoscopy, bronchoscopy, ENT endoscopy, urology endoscopy (cystoscopy), laparoscopy, obstetrics/gynecology endoscopy, arthroscopy, mediastinoscopy, and other applications. Among these, the bronchoscopy segment accounted for the second-largest share of the market in 2024. This is due to the rising global burden of respiratory disorders, particularly lung cancer. As per the American Cancer Society, approximately 226,650 new cases of lung cancer are projected in the US in 2025, underscoring the urgent need for early and accurate diagnostic tools. Flexible bronchoscopes enable direct visualization of the airways, tissue biopsy, and therapeutic interventions, which makes them indispensable in pulmonary care. Their minimally invasive nature, improved imaging capabilities, and use in inpatient and outpatient settings contribute to widespread clinical adoption. Moreover, increased awareness, early screening programs, and rising investments in respiratory diagnostics further drive segment growth.
Asia Pacific is projected to grow at the highest CAGR in the flexible endoscopes market during the forecast period.
The global flexible endoscopes market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the Asia Pacific region is projected to grow at the highest rate during the forecast period. This is primarily due to the development of healthcare infrastructure, increasing healthcare expenditure, and rising awareness of people regarding early disease detection across populous nations, such as China and India. These countries are investing heavily in enhancing diagnostic and surgical capabilities, particularly in managing the rising cases of chronic diseases, such as cancer and cardiovascular disorders. Japan's well-established healthcare system with universal insurance coverage ensures wide accessibility to advanced endoscopic procedures. The increasing medical tourism, favorable government initiatives, and the rising adoption of minimally invasive technologies are accelerating market penetration in the region, making it a high-growth region in the global flexible endoscopes market.
Tier 1 = > USD 10.0 billion, tier 2 = USD 1.0 billion to USD 10.0 billion, and tier 3 = < USD 1.0 billion
Key players operating in the flexible endoscopes market include Olympus Corporation (Japan), Karl STORZ SE & Co. KG (Germany), Boston Scientific Corporation (US), FUJIFILM Corporation (Japan), HOYA Corporation (Japan), Nipro (Japan), EndoMed Systems GmbH (Germany), Richard Wolf GmbH. (Germany), Ambu A/S (Denmark), Huger Medical Instrument Co., Ltd. (China), SonoScape Medical Corp (China), ATMOS MedizinTechnik GmbH & Co. KG (Germany), Stryker (US), Laborie (US), Endoscan Ltd. (UK), MGB BERLIN (Germany), Hunan Vathin Medical Instrument Co., Ltd. (China), OTU Medical (US), Zhuhai Pusen Medical Technology Co., Ltd. (China), Uroviu Corporation (US), ROPER TECHNOLOGIES, INC. (US), Optim LLC. (US), Clarus Medical LLC. (US), GI-View (Israel), Mitra Industries Private Limited (Ottomed), and Myelotec Co., Ltd (South Korea).
Research Coverage
This report studies the flexible endoscopes market based on type, application, end user, and region. The report also studies factors (drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and their respective countries).
Reasons to Buy the Report
The report will enable established and entrants/smaller firms to gauge the market's pulse, which, in turn, would help them gain a larger market share.